Advanced/Metastatic Gastroesophageal Adenocarcinoma
1 competing product in clinical development for Advanced/Metastatic Gastroesophageal Adenocarcinoma.
Pipeline by Phase
Phase 31
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Pembrolizumab + Lenvatinib + Oxaliplatin + Capecitabine + Leucovorin (or Levoleucovorin) + 5-FU | Eisai | Phase 3 | Active | 44 |